embecta Announces Earnings Conference Call Information for the Third Quarter of Fiscal Year 2022

Rhea-AI Summary

Embecta Corp. (NASDAQ: EMBC) announced it will report its third-quarter financial results for fiscal year 2022 on August 15, 2022. The company’s management will hold a conference call at 8:00 a.m. ET to discuss results and provide an operational update. Embecta is positioned as a significant player in diabetes care following its spin-off from Becton, Dickinson and Company on April 1, 2022. The live webcast of the call will be accessible through the company’s investor relations website.

Positive

• Embecta is one of the largest pure-play diabetes care companies globally.
• The upcoming earnings report allows investors to assess the company's financial health post-spin-off.

Negative

• None.

PARSIPPANY, N.J., July 05, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off from Becton, Dickinson and Company ("BD"), today announced that it will report its financial results for the third quarter of fiscal year 2022 before the market opens on Monday, August 15, 2022.

Management will host a conference call at 8:00 a.m. Eastern Time (ET) on August 15 to discuss the results of the quarter, provide an operational update, and host a question and answer session.

Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.

A webcast replay of the call will be available beginning at 11:00 a.m. ET on August 15, 2022, via the embecta investor relations website and archived on the website for one year.

About embecta 
embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com.

CONTACTS 
 
Investors:
Pravesh Khandelwal
VP, Head of Investor Relations
551-264-6547
Contact IR

Media:
Christian Glazar
Sr. Director, Corporate Communications 
908-821-6922 
Contact Media Relations 

FAQ

When will Embecta report its third-quarter results for fiscal year 2022?

Embecta will report its third-quarter financial results on August 15, 2022.

What time is Embecta's conference call for Q3 results?

The conference call is scheduled for 8:00 a.m. Eastern Time on August 15, 2022.

How can I access the live webcast of Embecta's earnings call?

The live webcast can be accessed through the company's investor relations website.

What is Embecta's stock symbol?

Embecta's stock symbol is EMBC.

What was the significance of Embecta's spin-off from Becton, Dickinson and Company?

The spin-off allows Embecta to focus solely on diabetes care, leveraging its legacy in insulin delivery.